Project Details
| Short title | TACE-2: A randomised placebo-controlled, double blinded, phase III trial of sorafenib in combination with Transarterial Chemoembolisation in hepatocellular cancer |
|---|---|
| Status | Active |
| Effective start/end date | 16/02/09 → 31/12/23 |
Funding
- University College London